A More Radical Solution

Title:A More Radical Solution

Volume: 10 Issue: 1

Author(s): Peter J. Lachmann

Affiliation:

Keywords: Phase 3, strict liability.

Abstract: The current modifications to licensing procedures still leave a basically flawed system in place. A more radical solution is proposed that involves dispensing with Phase 3 trials and making medicines available at the end of Phase 2 to those who are fully informed of the potential risks and benefits and wish to take part in this novel procedure. The advantages include a shorter development time, lower development costs and allowing smaller companies to take medicines to the clinic. The principal obstacle is that medicines are subject to strict liability rather than the tort of negligence – and this will have to be amended in due course.

Cite this article as:

Lachmann J. Peter, A More Radical Solution, Reviews on Recent Clinical Trials 2015; 10 (1) . https://dx.doi.org/10.2174/1574887110666150430151051